Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A
Clinical trial NCT01458106 · COMPLETED
Trial details
- NCT number
- NCT01458106
- Sponsor
- Bioverativ Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.